Publicaciones (119) Publicaciones en las que ha participado algún/a investigador/a

2011

  1. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): A report of the American college of cardiology foundation/American heart association task force on practice guidelines

    Circulation, Vol. 123, Núm. 1, pp. 104-123

  2. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

    Heart rhythm : the official journal of the Heart Rhythm Society, Vol. 8, Núm. 1, pp. 157-176

  3. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Heart Rhythm, Vol. 8, Núm. 3

  4. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): A report of the american college of cardiology foundation/American heart association task force on practice guidelines

    Journal of the American College of Cardiology, Vol. 57, Núm. 2, pp. 223-242

  5. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

    Circulation, Vol. 123, Núm. 10

  6. A mouse model of hemorrhagic transformation by delayed tissue plasminogen activator administration after in situ thromboembolic stroke

    Stroke, Vol. 42, Núm. 1, pp. 196-203

  7. Al final, el principio

    MoleQla: revista de Ciencias de la Universidad Pablo de Olavide, Núm. 4, pp. 37-40

  8. Antihypertensive effects of peroxisome proliferator-activated receptor-β activation in spontaneously hypertensive rats

    Hypertension, Vol. 58, Núm. 4, pp. 733-743

  9. Aportaciones de los medicamentos a la salud y calidad de vida de los pacientes (II)

    Actualidad en farmacología y terapéutica, Vol. 9, Núm. 4, pp. 279-290

  10. Apoyando la Investigación

    Actualidad en farmacología y terapéutica, Vol. 9, Núm. 4, pp. 235-236

  11. Benzodipyrrole derivates as new ionophores for anion-selective electrodes: Improving potentiometric selectivity towards divalent anions

    Talanta, Vol. 85, Núm. 4, pp. 1876-1881

  12. CCL2/MCP-1 modulation of microglial activation and proliferation

    Journal of Neuroinflammation, Vol. 8

  13. Calcium signalling mediated through α7 and non-α7 nAChR stimulation is differentially regulated in bovine chromaffin cells to induce catecholamine release

    British Journal of Pharmacology, Vol. 162, Núm. 1, pp. 94-110

  14. Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia-reperfusion injury in Zucker diabetic fatty rats: Role of CB2 receptors and iNOS/eNOS

    Diabetes/Metabolism Research and Reviews, Vol. 27, Núm. 4, pp. 331-340

  15. Carotid body function and ventilatory responses in intermittent hypoxia. evidence for anomalous brainstem integration of arterial chemoreceptor input

    Journal of Cellular Physiology, Vol. 226, Núm. 8, pp. 1961-1969

  16. Ceramide inhibits Kv currents and contributes to TP-receptor-induced vasoconstriction in rat and human pulmonary arteries

    American Journal of Physiology - Cell Physiology, Vol. 301, Núm. 1

  17. Changes in interleukin-1 signal modulators induced by 3,4-methylenedioxymethamphetamine (MDMA): Regulation by CB2 receptors and implications for neurotoxicity

    Journal of Neuroinflammation, Vol. 8

  18. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgerya cohort study

    Annals of Internal Medicine, Vol. 154, Núm. 8, pp. 523-528

  19. Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3- carbonitriles

    Bioorganic and Medicinal Chemistry, Vol. 19, Núm. 1, pp. 122-133

  20. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats

    British Journal of Nutrition, Vol. 106, Núm. 9, pp. 1337-1348